Malignant Ovarian Epithelial Tumor — Trials

Malignant Ovarian Epithelial Tumor — Trials · CancerIndex

Clinical trials

Registered studies

897 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 270
Recruiting: 140
Ph III recruiting: 16
Growth YoY: +23.1%
Industry share: 31%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (145)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05180851	Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study(YSCH-01)	unknown	Early Phase 1	28	Shanghai Fengxian District Central HospitalOTHER	1	Feb 1, 2022	clinicaltrials
NCT03692637	Study of Anti-Mesothelin Car NK Cells in Epithelial Ovarian Cancer	unknown	Early Phase 1	30	Allife Medical Science and Technology Co., Ltd.INDUSTRY	0	Jan 31, 2019